* Minerva Surgical Inc UTRS.OQ reported a quarterly
adjusted
loss of 40 cents per share for the quarter ended in September.
The mean expectation of two analysts for the quarter was for a
loss of 28 cents per share.
* Revenue rose 0.7% to $12.59 million from a year ago;
analysts
expected $12.60 million.
* Minerva Surgical Inc's reported EPS for the quarter was a
loss
of 40 cents.
* The mean earnings estimate of analysts was unchanged in
the last
three months.
* In the last 30 days there have been no earnings estimate
revisions by analysts covering the company.
* Minerva Surgical Inc shares had fallen by 64.2% this
quarter and
lost 94.5% so far this year.
* The company reported a quarterly loss of $11.33 million.
* Wall Street's median 12-month price target for Minerva
Surgical
Inc is $5.00
* The current average analyst rating on the shares is "hold"
and
the breakdown of recommendations is 1 "strong buy" or "buy," no
"hold" and 1 "sell" or "strong sell."
This summary was machine generated from Refinitiv data November
14 at 10:46 p.m. All figures in US dollars unless otherwise
stated. QUARTER ENDING ESTIMATE ACTUAL BEAT, MET,
MISSED
Sep. 30 2022 -0.28 -0.40 Missed
Jun. 30 2022 -0.34 -0.20 Beat
Mar. 31 2022 -0.31 -0.38 Missed
Dec. 31 2021 -0.29 -0.26 Beat